Roivant Sciences Ltd. SEC filings ROIV

Roivant Sciences Ltd. has 995 filings in SEC EDGAR's recent list, going back to Mar 16, 2015. Its latest annual report, Form ARS, was filed on Jul 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (regulation fd disclosure). The company's fiscal year ends on March 31.

Roivant Sciences Ltd. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 21, 2026 Oct 21, 2026
8-K Current report
Shareholder vote results
Sep 18, 2026 Sep 16, 2026
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
8-K Current report
Other events
Aug 28, 2026 Aug 28, 2026
8-K Current report
Regulation FD disclosure
Aug 27, 2026 Aug 27, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
ARS Annual report to shareholders Jul 29, 2026 Mar 31, 2026
DEFA14A Additional proxy material Jul 29, 2026 —
DEF 14A Proxy statement Jul 29, 2026 Sep 16, 2026
S-8 Employee stock plan registration May 20, 2026 —
10-K Annual report May 20, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 20, 2026 May 20, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Apr 2, 2026 Apr 2, 2026
8-K/A Amended current report
Material agreement
Mar 23, 2026 Mar 3, 2026
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Mar 3, 2026 Mar 3, 2026
8-K Current report
Regulation FD disclosure
Mar 3, 2026 Mar 3, 2026
10-Q Quarterly report Feb 6, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 6, 2026 Feb 6, 2026
8-K Current report
Regulation FD disclosure
Dec 11, 2025 Dec 11, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
S-3ASR Automatic shelf registration Oct 3, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Sep 17, 2025 Sep 17, 2025
8-K Current report
Shareholder vote results
Sep 11, 2025 Sep 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 3, 2025 Sep 3, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
ARS Annual report to shareholders Jul 29, 2025 Mar 31, 2025
DEF 14A Proxy statement Jul 29, 2025 Sep 10, 2025
DEFA14A Additional proxy material Jul 29, 2025 —
8-K Current report
Other events
Jun 25, 2025 Jun 24, 2025
10-K Annual report May 29, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 29, 2025 May 29, 2025
8-K Current report
Regulation FD disclosure
Apr 21, 2025 Apr 21, 2025
8-K Current report
Officer or director change
Mar 20, 2025 Mar 16, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 19, 2025 Mar 19, 2025
8-K Current report
Officer or director change
Feb 21, 2025 Feb 19, 2025
10-Q Quarterly report Feb 10, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 10, 2025 Feb 10, 2025
8-K Current report
Regulation FD disclosure
Dec 3, 2024 Dec 3, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Agreement ended, Regulation FD disclosure
Oct 28, 2024 Oct 28, 2024
8-K Current report
Material agreement
Sep 23, 2024 Sep 17, 2024
8-K Current report
Regulation FD disclosure
Sep 18, 2024 Sep 18, 2024
8-K Current report
Shareholder vote results
Sep 16, 2024 Sep 10, 2024
8-K Current report
Regulation FD disclosure
Sep 10, 2024 Sep 10, 2024
8-K Current report
Regulation FD disclosure
Sep 9, 2024 Sep 9, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
S-8 Employee stock plan registration Jul 26, 2024 —
ARS Annual report to shareholders Jul 26, 2024 Mar 31, 2024
DEFA14A Additional proxy material Jul 26, 2024 —
DEF 14A Proxy statement Jul 26, 2024 Sep 10, 2024
10-K Annual report May 30, 2024 Mar 31, 2024
8-K Current report
Material agreement
May 30, 2024 May 24, 2024
8-K Current report
Results of operations
May 30, 2024 May 30, 2024
8-K Current report
Other events
Apr 2, 2024 Apr 2, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 13, 2024 Feb 13, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 20, 2023 Dec 20, 2023
8-K/A Amended current report Dec 20, 2023 Dec 14, 2023
8-K Current report
Acquisition or sale of assets, Other events
Dec 14, 2023 Dec 14, 2023
8-K Current report
Other events
Nov 28, 2023 Nov 28, 2023
8-K Current report
Other events
Nov 27, 2023 Nov 27, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Material agreement, Other events
Oct 23, 2023 Oct 22, 2023
EFFECT Filing Oct 6, 2023 —
424B5 Prospectus supplement Oct 6, 2023 —
CORRESP Letter to the SEC Oct 4, 2023 —
UPLOAD Letter from the SEC Oct 4, 2023 —
S-3 Shelf registration Sep 29, 2023 —
8-K Current report
Material agreement
Sep 29, 2023 Sep 26, 2023
424B5 Prospectus supplement Sep 26, 2023 —
8-K Current report
Other events
Sep 26, 2023 Sep 26, 2023
8-K Current report
Shareholder vote results
Sep 15, 2023 Sep 12, 2023
8-K Current report
Other events
Sep 11, 2023 Sep 11, 2023
25-NSE Delisting notice Sep 1, 2023 —
8-K Current report
Other events
Aug 17, 2023 Aug 17, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
ARS Annual report to shareholders Aug 7, 2023 Mar 31, 2023
8-K Current report
Officer or director change
Aug 4, 2023 Jul 31, 2023
8-K Current report
Other events
Aug 2, 2023 Aug 2, 2023
DEFA14A Additional proxy material Jul 31, 2023 —
DEF 14A Proxy statement Jul 31, 2023 Sep 12, 2023
S-8 Employee stock plan registration Jun 29, 2023 —
8-K/A Amended current report
Results of operations
Jun 28, 2023 Jun 28, 2023
10-K Annual report Jun 28, 2023 Mar 31, 2023
8-K Current report
Results of operations
Jun 28, 2023 Jun 28, 2023
8-K Current report
Other events
Jun 22, 2023 Jun 22, 2023
8-K Current report
Other events
May 16, 2023 May 16, 2023
8-K Current report
Other events
Apr 4, 2023 Apr 4, 2023
8-K Current report
Officer or director change
Mar 16, 2023 Mar 13, 2023
8-K Current report
Other events
Mar 15, 2023 Mar 15, 2023
8-K Current report
Officer or director change
Feb 21, 2023 Feb 20, 2023
10-Q Quarterly report Feb 13, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 13, 2023 Feb 13, 2023
8-K Current report
Material agreement, Other events
Feb 7, 2023 Feb 2, 2023
424B5 Prospectus supplement Feb 6, 2023 —
424B5 Prospectus supplement Feb 1, 2023 —
8-K Current report
Results of operations
Feb 1, 2023 Feb 1, 2023
8-K Current report
Other events
Jan 4, 2023 Jan 4, 2023
8-K Current report
Regulation FD disclosure
Dec 1, 2022 Dec 1, 2022
8-K Current report
Officer or director change
Nov 23, 2022 Nov 17, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Material agreement, Other events
Nov 10, 2022 Nov 10, 2022
424B5 Prospectus supplement Nov 9, 2022 —
424B5 Prospectus supplement Nov 8, 2022 —
8-K Current report
Results of operations, Other events
Nov 7, 2022 Nov 7, 2022
EFFECT Filing Oct 3, 2022 —
EFFECT Filing Oct 3, 2022 —
EFFECT Filing Oct 3, 2022 —
EFFECT Filing Oct 3, 2022 —
424B7 Filing Oct 3, 2022 —
424B5 Prospectus supplement Oct 3, 2022 —
424B5 Prospectus supplement Oct 3, 2022 —
POS AM Filing Sep 29, 2022 —
POS AM Filing Sep 29, 2022 —
POS AM Filing Sep 29, 2022 —
8-K Current report
Regulation FD disclosure, Other events
Sep 28, 2022 Sep 28, 2022
8-K Current report
Agreement ended, Officer or director change, Shareholder vote results
Sep 21, 2022 Sep 15, 2022
S-3 Shelf registration Sep 19, 2022 —
424B3 Prospectus Aug 15, 2022 —
424B3 Prospectus Aug 15, 2022 —
424B3 Prospectus Aug 15, 2022 —
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
EFFECT Filing Aug 2, 2022 —
POS AM Filing Jul 29, 2022 —
DEFA14A Additional proxy material Jul 26, 2022 —
DEF 14A Proxy statement Jul 26, 2022 Sep 15, 2022
S-8 Employee stock plan registration Jun 28, 2022 —
424B3 Prospectus Jun 28, 2022 —
424B3 Prospectus Jun 28, 2022 —
424B3 Prospectus Jun 28, 2022 —
10-K Annual report Jun 28, 2022 Mar 31, 2022
8-K Current report
Results of operations, Officer or director change
Jun 28, 2022 Jun 22, 2022
424B3 Prospectus May 24, 2022 —
424B3 Prospectus May 24, 2022 —
424B3 Prospectus May 24, 2022 —
8-K Current report
Results of operations, Regulation FD disclosure
May 24, 2022 May 24, 2022
424B3 Prospectus Apr 1, 2022 —
EFFECT Filing Mar 31, 2022 —
S-1/A Amended registration statement Mar 31, 2022 —
424B3 Prospectus Mar 30, 2022 —
424B3 Prospectus Mar 30, 2022 —
8-K Current report
Regulation FD disclosure
Mar 30, 2022 Mar 30, 2022
CORRESP Letter to the SEC Mar 28, 2022 —
CORRESP Letter to the SEC Feb 28, 2022 —
424B3 Prospectus Feb 28, 2022 —
424B3 Prospectus Feb 28, 2022 —
8-K Current report
Regulation FD disclosure
Feb 28, 2022 Feb 28, 2022
CORRESP Letter to the SEC Feb 24, 2022 —
UPLOAD Letter from the SEC Feb 23, 2022 —
S-1 Registration statement Feb 17, 2022 —
424B3 Prospectus Feb 14, 2022 —
424B3 Prospectus Feb 14, 2022 —
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
8-K Current report
Material agreement, Results of operations, Unregistered share sale
Feb 14, 2022 Feb 14, 2022
EFFECT Filing Jan 4, 2022 —
424B3 Prospectus Jan 4, 2022 —
CORRESP Letter to the SEC Dec 30, 2021 —
UPLOAD Letter from the SEC Dec 29, 2021 —
S-1 Registration statement Dec 22, 2021 —
424B3 Prospectus Nov 15, 2021 —
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
EFFECT Filing Nov 9, 2021 —
424B3 Prospectus Nov 9, 2021 —
CORRESP Letter to the SEC Nov 5, 2021 —
UPLOAD Letter from the SEC Nov 5, 2021 —
S-1 Registration statement Oct 29, 2021 —
S-8 Employee stock plan registration Oct 8, 2021 —
CERT Filing Oct 1, 2021 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Oct 1, 2021 Sep 28, 2021
8-A12B/A Filing Sep 30, 2021 —
8-K Current report
Other events
Sep 28, 2021 Sep 28, 2021
10-Q Quarterly report Sep 21, 2021 Jun 30, 2021
8-K Current report
Results of operations
Sep 21, 2021 Sep 21, 2021
8-A12B Filing Sep 3, 2021 —
EFFECT Filing Aug 10, 2021 —
424B3 Prospectus Aug 10, 2021 —
SEC STAFF LETTER Filing Aug 10, 2021 —
S-4/A Filing Aug 9, 2021 —
CORRESP Letter to the SEC Aug 6, 2021 —
S-4/A Filing Aug 3, 2021 —
CORRESP Letter to the SEC Aug 3, 2021 —
425 Filing Aug 2, 2021 —
UPLOAD Letter from the SEC Jul 29, 2021 —
425 Form 8-k Jul 22, 2021 —
CORRESP Letter to the SEC Jul 22, 2021 —
S-4/A Filing Jul 22, 2021 —
UPLOAD Letter from the SEC Jul 15, 2021 —
425 Form 8-k Jul 1, 2021 —
S-4/A Filing Jul 1, 2021 —
CORRESP Letter to the SEC Jun 30, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ROIV (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Bermuda
Headquarters
London
SEC filer status
Large accelerated filer
SEC CIK
1635088

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.